Greenwich LifeSciences, Inc.
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
None right now.
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
0 sales (0 not pre-planned) · 5 purchases
- Patel SnehalCEO and CFO · Jul 29, 2026Bought 700 sharesabout $9 thousand ·
- Patel SnehalCEO and CFO · Jul 28, 2026Bought 1,500 sharesabout $20 thousand ·
- Patel SnehalCEO and CFO · Jul 27, 2026Bought 1,500 sharesabout $20 thousand ·
- Patel SnehalCEO and CFO · Jul 24, 2026Bought 1,100 sharesabout $14 thousand ·
- Patel SnehalCEO and CFO · Jul 23, 2026Bought 2,500 sharesabout $33 thousand ·
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.